SERUM TREATMENT OF INFLUENZAL MENINGITIS

M Wollstein1

  • 1Laboratories of the Rockefeller Institute for Medical Research, New York.

Insights

Developing an immune serum against Bacillus influenzae offers a promising treatment for influenzal meningitis. Subdural injection of this serum in monkeys successfully treated experimental meningitis, suggesting potential for human application.

Area of Science:

  • Medical Microbiology
  • Immunology
  • Neurology

Background:

  • Influenzal cerebrospinal meningitis is a severe, often fatal, condition in humans.
  • Experimental models are crucial for understanding disease pathogenesis and testing therapies.

Purpose of the Study:

  • To investigate the efficacy of an immune serum in treating experimental influenzal meningitis.
  • To evaluate the therapeutic potential of subdural serum injection for this condition.

Main Methods:

  • Induction of acute influenzal meningitis in monkeys via subdural injection of virulent Bacillus influenzae.
  • Production of an immune serum in goats through repeated injections of Bacillus influenzae.
  • Administration of the immune serum via subdural injection into affected monkeys.

Main Results:

  • Experimental meningitis in monkeys was lethal within 36 hours to 4 days.
  • Immune serum demonstrated moderate agglutinating and high opsonic power.
  • Subdural serum injection arrested meningitis progression and led to recovery in monkeys, with reduced bacterial load and inflammation.

Conclusions:

  • An immune serum produced in goats can effectively treat experimental influenzal meningitis in monkeys.
  • Subdural administration of this immune serum is a recommended therapeutic strategy.
  • Early diagnosis via cerebrospinal fluid microscopy and prompt, repeated serum injections are vital for successful treatment.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...